Research Portal

Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules.

Research output: Contribution to journal › Article › peer-review

Standard Standard

Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules. / Gonzalez, J.; Stern, P.; Dutta, S. et al.
In: International Journal of Research in Marketing, Vol. 25, No. 4, 01.12.2008, p. 247–260.

Research output: Contribution to journal › Article › peer-review

HarvardHarvard

Gonzalez, J, Stern, P, Dutta, S & Sismero, C 2008, 'Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules.', International Journal of Research in Marketing, vol. 25, no. 4, pp. 247–260. https://doi.org/10.1016/j.ijresmar.2008.08.002

APA

Gonzalez, J., Stern, P., Dutta, S., & Sismero, C. (2008). Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules. International Journal of Research in Marketing, 25(4), 247–260. https://doi.org/10.1016/j.ijresmar.2008.08.002

CBE

Gonzalez J, Stern P, Dutta S, Sismero C. 2008. Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules. International Journal of Research in Marketing. 25(4):247–260. https://doi.org/10.1016/j.ijresmar.2008.08.002

MLA

Gonzalez, J. et al. "Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules.". International Journal of Research in Marketing. 2008, 25(4). 247–260. https://doi.org/10.1016/j.ijresmar.2008.08.002

VancouverVancouver

Gonzalez J, Stern P, Dutta S, Sismero C. Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules. International Journal of Research in Marketing. 2008 Dec 1;25(4):247–260. doi: 10.1016/j.ijresmar.2008.08.002

Author

Gonzalez, J. ; Stern, P. ; Dutta, S. et al. / Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules. In: International Journal of Research in Marketing. 2008 ; Vol. 25, No. 4. pp. 247–260.

RIS

TY - JOUR

T1 - Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules.

AU - Gonzalez, J.

AU - Stern, P.

AU - Dutta, S.

AU - Sismero, C.

PY - 2008/12/1

Y1 - 2008/12/1

U2 - 10.1016/j.ijresmar.2008.08.002

DO - 10.1016/j.ijresmar.2008.08.002

M3 - Article

VL - 25

SP - 247

EP - 260

JO - International Journal of Research in Marketing

JF - International Journal of Research in Marketing

SN - 0167-8116

IS - 4

ER -